Table of Content

1 Remicade Biosimilar Market Overview
1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Remicade Biosimilar Segment by Type
1.2.1 Global Remicade Biosimilar Market Value Comparison by Type (2024-2034)
1.2.2 100mg/10ml
1.2.3 500mg/50ml
1.3 Remicade Biosimilar Segment by Application
1.3.1 Global Remicade Biosimilar Market Value by Application: (2024-2034)
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 Global Remicade Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Remicade Biosimilar Revenue 2018-2029
1.4.2 Global Remicade Biosimilar Sales 2018-2029
1.4.3 Global Remicade Biosimilar Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Remicade Biosimilar Market Competition by Manufacturers
2.1 Global Remicade Biosimilar Sales Market Share by Manufacturers (2018-2024)
2.2 Global Remicade Biosimilar Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Remicade Biosimilar Average Price by Manufacturers (2018-2024)
2.4 Global Remicade Biosimilar Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Remicade Biosimilar, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Remicade Biosimilar, Product Type & Application
2.7 Remicade Biosimilar Market Competitive Situation and Trends
2.7.1 Remicade Biosimilar Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Remicade Biosimilar Players Market Share by Revenue
2.7.3 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Remicade Biosimilar Retrospective Market Scenario by Region
3.1 Global Remicade Biosimilar Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Remicade Biosimilar Global Remicade Biosimilar Sales by Region: 2018-2029
3.2.1 Global Remicade Biosimilar Sales by Region: 2018-2024
3.2.2 Global Remicade Biosimilar Sales by Region: 2024-2029
3.3 Global Remicade Biosimilar Global Remicade Biosimilar Revenue by Region: 2018-2029
3.3.1 Global Remicade Biosimilar Revenue by Region: 2018-2024
3.3.2 Global Remicade Biosimilar Revenue by Region: 2024-2029
3.4 North America Remicade Biosimilar Market Facts & Figures by Country
3.4.1 North America Remicade Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Remicade Biosimilar Sales by Country (2018-2029)
3.4.3 North America Remicade Biosimilar Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Remicade Biosimilar Market Facts & Figures by Country
3.5.1 Europe Remicade Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Remicade Biosimilar Sales by Country (2018-2029)
3.5.3 Europe Remicade Biosimilar Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Remicade Biosimilar Market Facts & Figures by Country
3.6.1 Asia Pacific Remicade Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Remicade Biosimilar Sales by Country (2018-2029)
3.6.3 Asia Pacific Remicade Biosimilar Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Remicade Biosimilar Market Facts & Figures by Country
3.7.1 Latin America Remicade Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Remicade Biosimilar Sales by Country (2018-2029)
3.7.3 Latin America Remicade Biosimilar Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Country
3.8.1 Middle East and Africa Remicade Biosimilar Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Remicade Biosimilar Sales by Country (2018-2029)
3.8.3 Middle East and Africa Remicade Biosimilar Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Remicade Biosimilar Sales by Type (2018-2029)
4.1.1 Global Remicade Biosimilar Sales by Type (2018-2024)
4.1.2 Global Remicade Biosimilar Sales by Type (2024-2029)
4.1.3 Global Remicade Biosimilar Sales Market Share by Type (2018-2029)
4.2 Global Remicade Biosimilar Revenue by Type (2018-2029)
4.2.1 Global Remicade Biosimilar Revenue by Type (2018-2024)
4.2.2 Global Remicade Biosimilar Revenue by Type (2024-2029)
4.2.3 Global Remicade Biosimilar Revenue Market Share by Type (2018-2029)
4.3 Global Remicade Biosimilar Price by Type (2018-2029)
5 Segment by Application
5.1 Global Remicade Biosimilar Sales by Application (2018-2029)
5.1.1 Global Remicade Biosimilar Sales by Application (2018-2024)
5.1.2 Global Remicade Biosimilar Sales by Application (2024-2029)
5.1.3 Global Remicade Biosimilar Sales Market Share by Application (2018-2029)
5.2 Global Remicade Biosimilar Revenue by Application (2018-2029)
5.2.1 Global Remicade Biosimilar Revenue by Application (2018-2024)
5.2.2 Global Remicade Biosimilar Revenue by Application (2024-2029)
5.2.3 Global Remicade Biosimilar Revenue Market Share by Application (2018-2029)
5.3 Global Remicade Biosimilar Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Synthon Pharmaceuticals
6.1.1 Synthon Pharmaceuticals Corporation Information
6.1.2 Synthon Pharmaceuticals Description and Business Overview
6.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Synthon Pharmaceuticals Remicade Biosimilar Product Portfolio
6.1.5 Synthon Pharmaceuticals Recent Developments/Updates
6.2 LG Life Sciences
6.2.1 LG Life Sciences Corporation Information
6.2.2 LG Life Sciences Description and Business Overview
6.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.2.4 LG Life Sciences Remicade Biosimilar Product Portfolio
6.2.5 LG Life Sciences Recent Developments/Updates
6.3 Novartis (Sandoz)
6.3.1 Novartis (Sandoz) Corporation Information
6.3.2 Novartis (Sandoz) Description and Business Overview
6.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Novartis (Sandoz) Remicade Biosimilar Product Portfolio
6.3.5 Novartis (Sandoz) Recent Developments/Updates
6.4 Celltrion
6.4.1 Celltrion Corporation Information
6.4.2 Celltrion Description and Business Overview
6.4.3 Celltrion Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Celltrion Remicade Biosimilar Product Portfolio
6.4.5 Celltrion Recent Developments/Updates
6.5 Biocon
6.5.1 Biocon Corporation Information
6.5.2 Biocon Description and Business Overview
6.5.3 Biocon Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Biocon Remicade Biosimilar Product Portfolio
6.5.5 Biocon Recent Developments/Updates
6.6 Hospira
6.6.1 Hospira Corporation Information
6.6.2 Hospira Description and Business Overview
6.6.3 Hospira Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Hospira Remicade Biosimilar Product Portfolio
6.6.5 Hospira Recent Developments/Updates
6.7 Merck Serono (Merck Group)
6.6.1 Merck Serono (Merck Group) Corporation Information
6.6.2 Merck Serono (Merck Group) Description and Business Overview
6.6.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Merck Serono (Merck Group) Remicade Biosimilar Product Portfolio
6.7.5 Merck Serono (Merck Group) Recent Developments/Updates
6.8 Biogen idec Inc.
6.8.1 Biogen idec Inc. Corporation Information
6.8.2 Biogen idec Inc. Description and Business Overview
6.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Biogen idec Inc. Remicade Biosimilar Product Portfolio
6.8.5 Biogen idec Inc. Recent Developments/Updates
6.9 Genentech (Roche Group)
6.9.1 Genentech (Roche Group) Corporation Information
6.9.2 Genentech (Roche Group) Description and Business Overview
6.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Genentech (Roche Group) Remicade Biosimilar Product Portfolio
6.9.5 Genentech (Roche Group) Recent Developments/Updates
6.10 Fosun Pharmaceutical
6.10.1 Fosun Pharmaceutical Corporation Information
6.10.2 Fosun Pharmaceutical Description and Business Overview
6.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Fosun Pharmaceutical Remicade Biosimilar Product Portfolio
6.10.5 Fosun Pharmaceutical Recent Developments/Updates
6.11 Livzon Pharmaceutical
6.11.1 Livzon Pharmaceutical Corporation Information
6.11.2 Livzon Pharmaceutical Remicade Biosimilar Description and Business Overview
6.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Livzon Pharmaceutical Remicade Biosimilar Product Portfolio
6.11.5 Livzon Pharmaceutical Recent Developments/Updates
6.12 Anke Biotechnology
6.12.1 Anke Biotechnology Corporation Information
6.12.2 Anke Biotechnology Remicade Biosimilar Description and Business Overview
6.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Anke Biotechnology Remicade Biosimilar Product Portfolio
6.12.5 Anke Biotechnology Recent Developments/Updates
6.13 Hualan Biological Engineering
6.13.1 Hualan Biological Engineering Corporation Information
6.13.2 Hualan Biological Engineering Remicade Biosimilar Description and Business Overview
6.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Hualan Biological Engineering Remicade Biosimilar Product Portfolio
6.13.5 Hualan Biological Engineering Recent Developments/Updates
6.14 Walvax Biotechnology
6.14.1 Walvax Biotechnology Corporation Information
6.14.2 Walvax Biotechnology Remicade Biosimilar Description and Business Overview
6.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Walvax Biotechnology Remicade Biosimilar Product Portfolio
6.14.5 Walvax Biotechnology Recent Developments/Updates
6.15 Hisun Pharmaceutical
6.15.1 Hisun Pharmaceutical Corporation Information
6.15.2 Hisun Pharmaceutical Remicade Biosimilar Description and Business Overview
6.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Hisun Pharmaceutical Remicade Biosimilar Product Portfolio
6.15.5 Hisun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Remicade Biosimilar Industry Chain Analysis
7.2 Remicade Biosimilar Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Remicade Biosimilar Production Mode & Process
7.4 Remicade Biosimilar Sales and Marketing
7.4.1 Remicade Biosimilar Sales Channels
7.4.2 Remicade Biosimilar Distributors
7.5 Remicade Biosimilar Customers
8 Remicade Biosimilar Market Dynamics
8.1 Remicade Biosimilar Industry Trends
8.2 Remicade Biosimilar Market Drivers
8.3 Remicade Biosimilar Market Challenges
8.4 Remicade Biosimilar Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Remicade Biosimilar Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Remicade Biosimilar Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Remicade Biosimilar Market Competitive Situation by Manufacturers in 2022
Table 4. Global Remicade Biosimilar Sales (L) of Key Manufacturers (2018-2024)
Table 5. Global Remicade Biosimilar Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Remicade Biosimilar Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Remicade Biosimilar Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Remicade Biosimilar Average Price (US$/Ml) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Remicade Biosimilar, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Remicade Biosimilar, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Remicade Biosimilar, Product Type & Application
Table 12. Global Key Manufacturers of Remicade Biosimilar, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Remicade Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remicade Biosimilar as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Remicade Biosimilar Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Remicade Biosimilar Sales by Region (2018-2024) & (L)
Table 18. Global Remicade Biosimilar Sales Market Share by Region (2018-2024)
Table 19. Global Remicade Biosimilar Sales by Region (2024-2029) & (L)
Table 20. Global Remicade Biosimilar Sales Market Share by Region (2024-2029)
Table 21. Global Remicade Biosimilar Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Remicade Biosimilar Revenue Market Share by Region (2018-2024)
Table 23. Global Remicade Biosimilar Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Remicade Biosimilar Revenue Market Share by Region (2024-2029)
Table 25. North America Remicade Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 27. North America Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 28. North America Remicade Biosimilar Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Remicade Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Remicade Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 32. Europe Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 33. Europe Remicade Biosimilar Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Remicade Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Remicade Biosimilar Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Remicade Biosimilar Sales by Region (2018-2024) & (L)
Table 37. Asia Pacific Remicade Biosimilar Sales by Region (2024-2029) & (L)
Table 38. Asia Pacific Remicade Biosimilar Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Remicade Biosimilar Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Remicade Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 42. Latin America Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 43. Latin America Remicade Biosimilar Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Remicade Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Remicade Biosimilar Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 47. Middle East & Africa Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 48. Middle East & Africa Remicade Biosimilar Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Remicade Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Remicade Biosimilar Sales (L) by Type (2018-2024)
Table 51. Global Remicade Biosimilar Sales (L) by Type (2024-2029)
Table 52. Global Remicade Biosimilar Sales Market Share by Type (2018-2024)
Table 53. Global Remicade Biosimilar Sales Market Share by Type (2024-2029)
Table 54. Global Remicade Biosimilar Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Remicade Biosimilar Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Remicade Biosimilar Revenue Market Share by Type (2018-2024)
Table 57. Global Remicade Biosimilar Revenue Market Share by Type (2024-2029)
Table 58. Global Remicade Biosimilar Price (US$/Ml) by Type (2018-2024)
Table 59. Global Remicade Biosimilar Price (US$/Ml) by Type (2024-2029)
Table 60. Global Remicade Biosimilar Sales (L) by Application (2018-2024)
Table 61. Global Remicade Biosimilar Sales (L) by Application (2024-2029)
Table 62. Global Remicade Biosimilar Sales Market Share by Application (2018-2024)
Table 63. Global Remicade Biosimilar Sales Market Share by Application (2024-2029)
Table 64. Global Remicade Biosimilar Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Remicade Biosimilar Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Remicade Biosimilar Revenue Market Share by Application (2018-2024)
Table 67. Global Remicade Biosimilar Revenue Market Share by Application (2024-2029)
Table 68. Global Remicade Biosimilar Price (US$/Ml) by Application (2018-2024)
Table 69. Global Remicade Biosimilar Price (US$/Ml) by Application (2024-2029)
Table 70. Synthon Pharmaceuticals Corporation Information
Table 71. Synthon Pharmaceuticals Description and Business Overview
Table 72. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 73. Synthon Pharmaceuticals Remicade Biosimilar Product
Table 74. Synthon Pharmaceuticals Recent Developments/Updates
Table 75. LG Life Sciences Corporation Information
Table 76. LG Life Sciences Description and Business Overview
Table 77. LG Life Sciences Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 78. LG Life Sciences Remicade Biosimilar Product
Table 79. LG Life Sciences Recent Developments/Updates
Table 80. Novartis (Sandoz) Corporation Information
Table 81. Novartis (Sandoz) Description and Business Overview
Table 82. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 83. Novartis (Sandoz) Remicade Biosimilar Product
Table 84. Novartis (Sandoz) Recent Developments/Updates
Table 85. Celltrion Corporation Information
Table 86. Celltrion Description and Business Overview
Table 87. Celltrion Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 88. Celltrion Remicade Biosimilar Product
Table 89. Celltrion Recent Developments/Updates
Table 90. Biocon Corporation Information
Table 91. Biocon Description and Business Overview
Table 92. Biocon Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 93. Biocon Remicade Biosimilar Product
Table 94. Biocon Recent Developments/Updates
Table 95. Hospira Corporation Information
Table 96. Hospira Description and Business Overview
Table 97. Hospira Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 98. Hospira Remicade Biosimilar Product
Table 99. Hospira Recent Developments/Updates
Table 100. Merck Serono (Merck Group) Corporation Information
Table 101. Merck Serono (Merck Group) Description and Business Overview
Table 102. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 103. Merck Serono (Merck Group) Remicade Biosimilar Product
Table 104. Merck Serono (Merck Group) Recent Developments/Updates
Table 105. Biogen idec Inc. Corporation Information
Table 106. Biogen idec Inc. Description and Business Overview
Table 107. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 108. Biogen idec Inc. Remicade Biosimilar Product
Table 109. Biogen idec Inc. Recent Developments/Updates
Table 110. Genentech (Roche Group) Corporation Information
Table 111. Genentech (Roche Group) Description and Business Overview
Table 112. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 113. Genentech (Roche Group) Remicade Biosimilar Product
Table 114. Genentech (Roche Group) Recent Developments/Updates
Table 115. Fosun Pharmaceutical Corporation Information
Table 116. Fosun Pharmaceutical Description and Business Overview
Table 117. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 118. Fosun Pharmaceutical Remicade Biosimilar Product
Table 119. Fosun Pharmaceutical Recent Developments/Updates
Table 120. Livzon Pharmaceutical Corporation Information
Table 121. Livzon Pharmaceutical Description and Business Overview
Table 122. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 123. Livzon Pharmaceutical Remicade Biosimilar Product
Table 124. Livzon Pharmaceutical Recent Developments/Updates
Table 125. Anke Biotechnology Corporation Information
Table 126. Anke Biotechnology Description and Business Overview
Table 127. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 128. Anke Biotechnology Remicade Biosimilar Product
Table 129. Anke Biotechnology Recent Developments/Updates
Table 130. Hualan Biological Engineering Corporation Information
Table 131. Hualan Biological Engineering Description and Business Overview
Table 132. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 133. Hualan Biological Engineering Remicade Biosimilar Product
Table 134. Hualan Biological Engineering Recent Developments/Updates
Table 135. Walvax Biotechnology Corporation Information
Table 136. Walvax Biotechnology Description and Business Overview
Table 137. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 138. Walvax Biotechnology Remicade Biosimilar Product
Table 139. Walvax Biotechnology Recent Developments/Updates
Table 140. Hisun Pharmaceutical Corporation Information
Table 141. Hisun Pharmaceutical Description and Business Overview
Table 142. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 143. Hisun Pharmaceutical Remicade Biosimilar Product
Table 144. Hisun Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Remicade Biosimilar Distributors List
Table 148. Remicade Biosimilar Customers List
Table 149. Remicade Biosimilar Market Trends
Table 150. Remicade Biosimilar Market Drivers
Table 151. Remicade Biosimilar Market Challenges
Table 152. Remicade Biosimilar Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Remicade Biosimilar
Figure 2. Global Remicade Biosimilar Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Remicade Biosimilar Market Share by Type in 2022 & 2029
Figure 4. 100mg/10ml Product Picture
Figure 5. 500mg/50ml Product Picture
Figure 6. Global Remicade Biosimilar Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Remicade Biosimilar Market Share by Application in 2022 & 2029
Figure 8. Blood Disorders
Figure 9. Oncology Diseases
Figure 10. Global Remicade Biosimilar Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Remicade Biosimilar Market Size (2018-2029) & (US$ Million)
Figure 12. Global Remicade Biosimilar Sales (2018-2029) & (L)
Figure 13. Global Remicade Biosimilar Average Price (US$/Ml) & (2018-2029)
Figure 14. Remicade Biosimilar Report Years Considered
Figure 15. Remicade Biosimilar Sales Share by Manufacturers in 2022
Figure 16. Global Remicade Biosimilar Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Remicade Biosimilar Players: Market Share by Revenue in 2022
Figure 18. Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Remicade Biosimilar Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Remicade Biosimilar Sales Market Share by Country (2018-2029)
Figure 21. North America Remicade Biosimilar Revenue Market Share by Country (2018-2029)
Figure 22. United States Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Remicade Biosimilar Sales Market Share by Country (2018-2029)
Figure 25. Europe Remicade Biosimilar Revenue Market Share by Country (2018-2029)
Figure 26. Germany Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Remicade Biosimilar Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Remicade Biosimilar Revenue Market Share by Region (2018-2029)
Figure 33. China Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Remicade Biosimilar Sales Market Share by Country (2018-2029)
Figure 43. Latin America Remicade Biosimilar Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Remicade Biosimilar Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Remicade Biosimilar Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Remicade Biosimilar Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Remicade Biosimilar by Type (2018-2029)
Figure 53. Global Revenue Market Share of Remicade Biosimilar by Type (2018-2029)
Figure 54. Global Remicade Biosimilar Price (US$/Ml) by Type (2018-2029)
Figure 55. Global Sales Market Share of Remicade Biosimilar by Application (2018-2029)
Figure 56. Global Revenue Market Share of Remicade Biosimilar by Application (2018-2029)
Figure 57. Global Remicade Biosimilar Price (US$/Ml) by Application (2018-2029)
Figure 58. Remicade Biosimilar Value Chain
Figure 59. Remicade Biosimilar Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed